Functional assays have shown that these mutations lead to stabilization of HIF1α, causing overexpression of hypoxia-induced angiogenic pathway genes, such as VEGF (vascular endothelial growth factor) and EPAS1 (endothelial PAS domain protein 1), providing therefore support for tumor growth [116–118]. The gene discussed is VEGFA; the disease is neoplasm.